US Stock MarketDetailed Quotes

CNSP CNS Pharmaceuticals

Watchlist
  • 0.2162
  • -0.0014-0.64%
Close May 31 16:00 ET
  • 0.2064
  • -0.0098-4.53%
Post 17:38 ET
2.56MMarket Cap-76P/E (TTM)

CNS Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-28.05%3.54M
23.57%18.87M
4.77%5.38M
32.61%4.53M
12.93%4.03M
56.44%4.93M
5.39%15.27M
57.91%5.13M
-10.34%3.42M
-6.48%3.56M
Selling and administrative expenses
-17.98%1.11M
-20.07%4.77M
-48.54%1.11M
-7.25%1.12M
-12.15%1.18M
7.80%1.36M
27.48%5.97M
140.15%2.15M
-1.97%1.21M
17.16%1.34M
-General and administrative expense
-17.98%1.11M
-20.07%4.77M
-48.54%1.11M
-7.25%1.12M
-12.15%1.18M
7.80%1.36M
27.48%5.97M
140.15%2.15M
-1.97%1.21M
17.16%1.34M
Research and development costs
-31.88%2.43M
51.56%14.1M
43.25%4.27M
54.47%3.41M
28.10%2.85M
88.89%3.57M
-5.15%9.3M
26.61%2.98M
-14.36%2.21M
-16.65%2.22M
Operating profit
28.05%-3.54M
-23.57%-18.87M
-4.77%-5.38M
-32.61%-4.53M
-12.93%-4.03M
-56.44%-4.93M
-5.39%-15.27M
-57.91%-5.13M
10.34%-3.42M
6.48%-3.56M
Net non-operating interest income expense
101.95%106
297.55%13.88K
278.24%4.12K
2,152.97%11.05K
357.73%4.15K
-111.85%-5.44K
24.32%-7.03K
-3.31%-2.31K
43.19%-538
31.53%-1.61K
Non-operating interest income
--6.73K
--27.69K
--7K
--12.88K
--7.8K
--0
--0
--0
--0
--0
Non-operating interest expense
21.87%6.63K
96.46%13.81K
24.61%2.88K
241.64%1.84K
126.57%3.65K
111.85%5.44K
-24.32%7.03K
3.31%2.31K
-43.19%538
-31.53%1.61K
Other net income (expense)
Income before tax
28.13%-3.54M
-23.42%-18.85M
-4.64%-5.38M
-32.26%-4.52M
-12.77%-4.02M
-56.48%-4.93M
-5.37%-15.27M
-57.87%-5.14M
10.35%-3.42M
6.50%-3.57M
Income tax
Net income
28.13%-3.54M
-23.42%-18.85M
-4.64%-5.38M
-32.26%-4.52M
-12.77%-4.02M
-56.48%-4.93M
-5.37%-15.27M
-57.87%-5.14M
10.35%-3.42M
6.50%-3.57M
Net income continuous Operations
28.13%-3.54M
-23.42%-18.85M
-4.64%-5.38M
-32.26%-4.52M
-12.77%-4.02M
-56.48%-4.93M
-5.37%-15.27M
-57.87%-5.14M
10.35%-3.42M
6.50%-3.57M
Minority interest income
Net income attributable to the parent company
28.13%-3.54M
-23.42%-18.85M
-4.64%-5.38M
-32.26%-4.52M
-12.77%-4.02M
-56.48%-4.93M
-5.37%-15.27M
-57.87%-5.14M
10.35%-3.42M
6.50%-3.57M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
28.13%-3.54M
-23.42%-18.85M
-4.64%-5.38M
-32.26%-4.52M
-12.77%-4.02M
-56.48%-4.93M
-5.37%-15.27M
-57.87%-5.14M
10.35%-3.42M
6.50%-3.57M
Basic earnings per share
84.17%-0.41
10.87%-10
75.64%-0.8649
57.81%-1.08
61.05%-1.04
-6.15%-2.59
32.00%-11.22
1.39%-3.55
39.05%-2.56
40.67%-2.67
Diluted earnings per share
84.17%-0.41
10.87%-10
75.64%-0.8649
57.81%-1.08
61.05%-1.04
-6.15%-2.59
32.00%-11.22
1.39%-3.55
39.05%-2.56
40.67%-2.67
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -28.05%3.54M23.57%18.87M4.77%5.38M32.61%4.53M12.93%4.03M56.44%4.93M5.39%15.27M57.91%5.13M-10.34%3.42M-6.48%3.56M
Selling and administrative expenses -17.98%1.11M-20.07%4.77M-48.54%1.11M-7.25%1.12M-12.15%1.18M7.80%1.36M27.48%5.97M140.15%2.15M-1.97%1.21M17.16%1.34M
-General and administrative expense -17.98%1.11M-20.07%4.77M-48.54%1.11M-7.25%1.12M-12.15%1.18M7.80%1.36M27.48%5.97M140.15%2.15M-1.97%1.21M17.16%1.34M
Research and development costs -31.88%2.43M51.56%14.1M43.25%4.27M54.47%3.41M28.10%2.85M88.89%3.57M-5.15%9.3M26.61%2.98M-14.36%2.21M-16.65%2.22M
Operating profit 28.05%-3.54M-23.57%-18.87M-4.77%-5.38M-32.61%-4.53M-12.93%-4.03M-56.44%-4.93M-5.39%-15.27M-57.91%-5.13M10.34%-3.42M6.48%-3.56M
Net non-operating interest income expense 101.95%106297.55%13.88K278.24%4.12K2,152.97%11.05K357.73%4.15K-111.85%-5.44K24.32%-7.03K-3.31%-2.31K43.19%-53831.53%-1.61K
Non-operating interest income --6.73K--27.69K--7K--12.88K--7.8K--0--0--0--0--0
Non-operating interest expense 21.87%6.63K96.46%13.81K24.61%2.88K241.64%1.84K126.57%3.65K111.85%5.44K-24.32%7.03K3.31%2.31K-43.19%538-31.53%1.61K
Other net income (expense)
Income before tax 28.13%-3.54M-23.42%-18.85M-4.64%-5.38M-32.26%-4.52M-12.77%-4.02M-56.48%-4.93M-5.37%-15.27M-57.87%-5.14M10.35%-3.42M6.50%-3.57M
Income tax
Net income 28.13%-3.54M-23.42%-18.85M-4.64%-5.38M-32.26%-4.52M-12.77%-4.02M-56.48%-4.93M-5.37%-15.27M-57.87%-5.14M10.35%-3.42M6.50%-3.57M
Net income continuous Operations 28.13%-3.54M-23.42%-18.85M-4.64%-5.38M-32.26%-4.52M-12.77%-4.02M-56.48%-4.93M-5.37%-15.27M-57.87%-5.14M10.35%-3.42M6.50%-3.57M
Minority interest income
Net income attributable to the parent company 28.13%-3.54M-23.42%-18.85M-4.64%-5.38M-32.26%-4.52M-12.77%-4.02M-56.48%-4.93M-5.37%-15.27M-57.87%-5.14M10.35%-3.42M6.50%-3.57M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 28.13%-3.54M-23.42%-18.85M-4.64%-5.38M-32.26%-4.52M-12.77%-4.02M-56.48%-4.93M-5.37%-15.27M-57.87%-5.14M10.35%-3.42M6.50%-3.57M
Basic earnings per share 84.17%-0.4110.87%-1075.64%-0.864957.81%-1.0861.05%-1.04-6.15%-2.5932.00%-11.221.39%-3.5539.05%-2.5640.67%-2.67
Diluted earnings per share 84.17%-0.4110.87%-1075.64%-0.864957.81%-1.0861.05%-1.04-6.15%-2.5932.00%-11.221.39%-3.5539.05%-2.5640.67%-2.67
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg